Research programme: osteoarthritis therapy - Canadian Arthritis Network/GeneNews

Drug Profile

Research programme: osteoarthritis therapy - Canadian Arthritis Network/GeneNews

Alternative Names: Osteoarthritis therapy research programme - Canadian Arthritis Network/GeneNews

Latest Information Update: 01 Jun 2007

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Canadian Arthritis Network; GeneNews Limited
  • Class
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Osteoarthritis

Most Recent Events

  • 01 Jun 2007 Discontinued - Preclinical for Osteoarthritis in Canada (unspecified route)
  • 03 Nov 2006 ChondroGene is now called GeneNews
  • 04 Dec 2003 Preclinical trials in Osteoarthritis in Canada (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top